Studies visual nerve injury and blood markers in multiple sclerosis
Observes how eye, brain and blood changes relate to disability in multiple sclerosis.
Key facts
- Who runs it
- Cedars-Sinai Medical Center
- Where
- Los Angeles, United StatesSee the site
- Trial code
- Registry title
- MS-ResearchBiomarkerS
- Status
- Recruiting
- People taking part
- 1,000 people, planned
- Started
- 11 Nov 2021
- Expected to end
- 11 Nov 2041
- Type of study
- Observational, 5 groups
- Record updated
- 6 February 2024
Who can take part
AI summary
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for adults with multiple sclerosis or related disorders, other neurological disorders, or healthy volunteers. It studies eye tests, blood markers and MRI scans.
- Age
- 18 years or older
- Sex
- All sexes can join
- Disease stage
- Multiple sclerosis, clinically isolated syndrome, radiologically isolated syndrome, neuromyelitis optica spectrum disorder, MOG-related disease, other neurological disorders, or healthy volunteers.
Main reasons for not taking part
- Cannot join the MRI parts if they have metal implants, foreign bodies, claustrophobia, or an MRI-incompatible pacemaker or heart valve
- Cannot join the MRI parts if pregnant
- Cannot join the eye test parts if they had eye surgery in the past two months
- Cannot join the eye test parts if they have refractive errors of ±6 diopters or more
- Cannot join the eye test parts if they have eye diseases such as macular degeneration, diabetic retinopathy or glaucoma
The registry criteria, word for word
Show all 6 criteriaShow less
Who can take part
- Subjects who meet any one of the following diagnostic criteria:; Diagnosis of MS, CIS,or RIS based on the 2017 revised McDonald criteria; Diagnosis of NMOSD based on the 2015 revised NMOSD consensus diagnostic criteria; Diagnosis of myelin oligodendrocyte glycoprotein (MOG)-related encephalomyelitis, optic neuritis, or other associated disease; Diagnosis of neurological disorders other than MSRD; Healthy volunteer
- Age ≥18
- Able to give informed consent
Who cannot take part
- Patients will be excluded from the MRI portions of the study if they have a contraindication to MRI(metallic implantsor foreign bodies, claustrophobia, MRI-incompatible pacemakers, MRI- incompatible prosthetic heart valves)
- Patients will be excluded from the visual assessment portions of the study if they have had any recent ocular surgery (within the past two months), refractive errors of greater than or equal to ±6 diopters or other eye diseases that may affect or confound OCT/OCTA measurements (ex., age-related macular degeneration, advanced geographic atrophy, diabetic retinopathy, glaucoma)
- Patients will be excluded from the MRI portions of the study if they are pregnant, but their demographic, clinical information,and disability measures may still be captured under the study
Where in United States
- Cedars-Sinai Medical CenterLos Angeles, United StatesContact: Omar Al-Louzi, MDTaking people
About the trial
What the trial wants to find out
This study is being conducted to investigate risk factors for disability progression in Multiple Sclerosis and related disorders (MSRD). The primary goal is to assess whether combining information from visual assessment, blood markers, as well as historical and ongoing longitudinal MRIs of the brain, orbit (the part of the skull where eyes are located), and/or spinal cord can predict changes in quantitative disability measures related to MSRD and neurological disease.
The 5 groups in the trial
- RRMS, SPMS, PPMS, CIS or RIS
Multiple Sclerosis (relapsing-remitting, primary or secondary progressive forms), clinically isolated syndrome, or radiologically isolated syndrome
- NMOSD
Neuromyelitis optica spectrum disorders
- MOGAD
Myelin oligodendrocyte glycoprotein antibody disorders
- Neurological disorder other than MSRD
Neurological disorders due to neurodegenerative, vascular, or headache conditions that are not related to multiple sclerosis or related disorders.
- Healthy controls
Healthy controls with no known neurological conditions
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Investigating the Longitudinal Relationships Between Visual Pathway Injury, Radiological and Blood Biomarkers in Multiple Sclerosis and Related Disorders
- Plain-language title
- Studies visual nerve injury and blood markers in multiple sclerosisGenerated from the registry record. The registry title is the official one.
- AI summary
- From the trial's eligibility criteria. Read by machine on 12 November 2026.
- Publications
- Paramagnetic Rim Lesions Are Associated With Trans-Synaptic Degeneration of the Visual Pathway in Multiple Sclerosis.Annals of clinical and translational neurology, 2026
- Record updated
- 6 February 2024